search query: @indexterm PHARMACEUTICAL INDUSTRY / total: 673
references: 91-100 / 673
« previous page | next page »
 titleyearauthor
91.
Drivers of organizational creativity: a path model of creative climate in pharmaceutical R&D
R & D Management
2005 : SEP, VOL. 35:4, p. 359-374
 2005 Sundgren, M. (et al.)
92.
Regulatory oversight or lack of foresight? Implications for product recall policies and procedures
Journal of Consumer Policy
2005 : DEC, VOL 28:4, p. 433-460
 2005 Eagle, L. (et al.)
93.
Testing drugs on animals: a test case for socially responsible investment
Business Ethics
2005 : APR, VOL 14:2, p. 164-175
 2005 Taylor, R.
94.
International pricing and distribution of therapeutic pharmaceuticals - an ethical minefield
Business Ethics
2005 : APR, VOL 14:2, p. 127-141
 2005 Buckley, J.
Tuama, S. Ó.
95.
International pricing and distribution of therapeutic pharmaceuticals - an ethical minefield
Business Ethics
2005 : APR, VOL 14:2, p. 127-141
 2005 Buckley, J.
Tuama, S. Ó.
96.
Systems marketing: a new operating model for pharmaceutical marketing
Journal of Consumer Behaviour
2005 : DEC, VOL. 4:6, p. 480-495
 2005 Singer, J.
97.
Integrating strategic groups and the resource based perspective: understanding the competitive process
European Management Journal
2005 : AUG, VOL. 23:4, p. 458-470
 2005 Leask, G.
Parnell, J. A.
98.
Structural vs. relational embeddedness: social capital and managerial performance
Strategic Management Journal
2005 : DEC, VOL. 26:12, p. 1129-1151
 2005 Moran, P.
99.
Acknowledging the purpose of partnership
Journal of Business Ethics
2005 : JUL II, VOL. 59:4, p. 307-317
 2005 Macdonald, S.
Chrisp, T.
100.
Direct-to-consumer prescription drug advertising: understanding its consequences
International Journal of Advertising
2005 : VOL. 24:4, p. 441-466
 2005 Huh, J.
Becker, L.B.
« previous page | next page »
SCIMA